<DOC>
	<DOC>NCT00990808</DOC>
	<brief_summary>This study will investigate the effect of MK0859 on lipoprotein metabolism in patients with dyslipidemia already on statin therapy.</brief_summary>
	<brief_title>The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3)</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Anacetrapib</mesh_term>
	<mesh_term>Oxazolidinones</mesh_term>
	<criteria>Patient's weight has been stable for at least 6 weeks Patient is in good health based on medical history, physical exam, and laboratory tests Patient has dyslipidemia Exclusion Criteria : Patient has a history of stroke, seizures, or major neurological disorders Patient has a history of cancer Patient is currently taking any lipidlowering medications or substances except for statins Patient consumes excessive amounts of alcohol or caffeine Patient has multiple and/or severe allergies to food or drugs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>